Propranolol - intranasal - Questcor

Drug Profile

Propranolol - intranasal - Questcor

Alternative Names: Migrastat

Latest Information Update: 17 Oct 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Questcor Pharmaceuticals
  • Class Antihypertensives; Antimigraines; Class II antiarrhythmics; Ischaemic heart disorder therapies; Naphthalenes; Propanolamines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Migraine

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 13 Oct 2005 Discontinued - Phase-II for Migraine in USA (Intranasal)
  • 15 Jan 2003 Propranolol intranasal is available for licensing (www.questcor.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top